| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9259970c022e0559e7124255955d0cb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c152cf0c2bd684e03aad6629dd5e02f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8da6cf72afa1eee561bccb33ae1a2bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eb4a4763e9655fc28705ec7840bdb35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdcdddccb2e471a472ef23b67864a898 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-50 |
| filingDate |
2020-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13392cfebb2214dd44a831efae59527e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea5ae6fa66573bcc60514c883dfe279d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ba072f079cf487d6b04a3b1236e4913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e63be1d291f85e7aab94879c0d2a25d8 |
| publicationDate |
2021-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3914359-A1 |
| titleOfInvention |
Triphenylphosphonium-tethered salicylamine derivatives |
| abstract |
Novel salicylamine derivatives are targeted directly to the mitochondria to increase effectiveness and lower required dosages in the treatment of conditions caused by inflammation or oxidative stress. |
| priorityDate |
2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |